Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Sinensky Michael10% Owner | Gift | G | — 3.00M sh | Oct 30, 2026 |
| 20 | Hoffmann Michael ThomasEVP & General Counsel | Tax withholding | F | $82K 323 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 20 | Rooney Robert GeraldDirector | NONETCW Private Asset Income Fund Disposition to issuer | D | $100K 10.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 20 | Saba Capital Management, L.P.10% Owner | Open-market sale | SELL | $587K 43.0K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 20 | Jensen Christopher LEVP, Chief People Officer | Tax withholding | F | $152K 599 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 19 | Ruppel DavidSVP & GM Transportation Bus. | Option exercise | M | $280K 1,112 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 19 | Kell Sean DavisDirector | Open-market sale · 10b5-1 plan | SELL | $209K 10.3K sh | Oct 30, 2026 traded Oct 30, 2026 |
| 19 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $811K 1,906 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 19 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $369K 865 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 19 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $346K 6,899 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 19 | Hancock MarkDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $452K 9,024 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 18 | Frey Anthony GeorgeSVP and Chief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $89K 1,500 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 18 | Jacobs Kevin JSee Remarks | Option exercise | M | $1.07M 12.8K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 18 | Livschitz LeonardDirector, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $90K 10.0K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 18 | Frey Anthony GeorgeSVP and Chief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $184K 3,131 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 18 | Jacobs Kevin JSee Remarks | Option exercise | M | $3.26M 16.0K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 18 | Jacobs Kevin JSee Remarks | Option exercise | M | $1.59M 6,127 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 17 | Jensen Christopher LEVP, Chief People Officer | Option exercise | M | — 1,549 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Open-market sale | SELL | $69K 3,321 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 17 | Andrews LockieDirector | Grant or award | A | — 2,857 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Betz WilliamEVP & CFO | Option exercise | M | — 1,737 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Jensen Christopher LEVP, Chief People Officer | Option exercise | M | — 1,549 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Benacci Nancy CunninghamDirector | Grant or award | A | — 2,857 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Baxter Nathan EricDirector, President and CEO, 10% Owner | Grant or award | A | — 23.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Hardy AndrewEVP, Chief Sales Officer | Option exercise | M | — 1,080 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Ronald Ivan EdwardChief Financial Officer | Tax withholding | F | $15K 6,259 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 17 | Baker JeffPrincipal Accounting Officer | Option exercise | M | — 12.5K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 17 | Newinski Laura MarieDirector | NABrookfield Private Equity Fund LP Grant or award | A | — 1,304 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 17 | Betz WilliamEVP & CFO | Option exercise | M | — 1,737 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 17 | Sotomayor RafaelCEO & President | Option exercise | M | — 4,930 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 16 | Wunsch Scott MCEO, Logistics | Tax withholding | F | $214K 45.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $133K 313 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 16 | Subotovsky SantiagoDirector | Open-market sale · 10b5-1 plan | SELL | $144K 1,442 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 16 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Grant or award | A | — 6,815 sh | Oct 30, 2026 traded Oct 15, 2026 |
| 15 | McClain SeanDirector, Chief Executive Officer | Tax withholding | F | $966K 79.9K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 14 | Gryzlov YuryCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $110K 10.5K sh | Oct 30, 2026 traded Oct 30, 2026 |
| 14 | Sankar ShyamSee Remarks | Grant or award | A | — 564.8K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 14 | Taylor Ryan D.See Remarks | Grant or award | A | — 211.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 14 | Lewis Michelle ReneeChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $118K 2,364 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $7.32M 200.0K sh | Oct 30, 2026 traded Oct 28, 2026 |